ALIVUS
Invest with MTF
Invest Now
Invest in Alivus Life Sciences with 3.17X leverage
Performance
- Low
- ₹921
- High
- ₹939
- 52 Week Low
- ₹819
- 52 Week High
- ₹1,251
- Open Price₹936
- Previous Close₹939
- Volume28,805
- 50 DMA₹907.43
- 100 DMA₹920.45
- 200 DMA₹946.90
Investment Returns
- Over 1 Month + 1.39%
- Over 3 Month + 2.4%
- Over 6 Month -4.15%
- Over 1 Year -23.81%
Smart Investing Starts Here Start SIP with Alivus Life Sciences for Steady Growth!
Alivus Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 20.9
- PEG Ratio
- 0.9
- Market Cap Cr
- 11,361
- P/B Ratio
- 3.8
- Average True Range
- 33.07
- EPS
- 45.82
- Dividend Yield
- 0.5
- MACD Signal
- 5.86
- RSI
- 54.26
- MFI
- 43.52
Alivus Life Sciences Financials
Alivus Life Sciences Technicals
EMA & SMA
Current Price
₹925.65
-13.4
(-1.43%)
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹912.72
- 50 Day
- ₹907.43
- 100 Day
- ₹920.45
- 200 Day
- ₹946.90
Resistance and Support
928.57
- R3 954.18
- R2 946.62
- R1 936.13
- S1 918.08
- S2 910.52
- S3 900.03
Alivus Life Sciences Corporate Actions - Bonus, Splits, Dividends
Alivus Life Sciences F&O
About Alivus Life Sciences
- NSE Symbol
- ALIVUS
- BSE Symbol
- 543322
- Managing Director & CEO
- Dr. Yasir Rawjee
- ISIN
- INE03Q201024
Similar Stocks to Alivus Life Sciences
Alivus Life Sciences FAQs
Alivus Life Sciences share price is ₹925 As on 06 February, 2026 | 03:11
The Market Cap of Alivus Life Sciences is ₹11361.1 Cr As on 06 February, 2026 | 03:11
The P/E ratio of Alivus Life Sciences is 20.9 As on 06 February, 2026 | 03:11
The PB ratio of Alivus Life Sciences is 3.8 As on 06 February, 2026 | 03:11
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.